Diana Ernst

RPh

Most Recent Articles by Diana Ernst

Opioid, Gabapentin Combo Rx May Increase Mortality Risk

Opioid, Gabapentin Combo Rx May Increase Mortality Risk

By

Both gabapentin and opioids are commonly prescribed for the treatment of pain, making the likelihood of these two agents being prescribed together high.

FDA Approves New Treatment for Diabetic Peripheral Neuropathy, Postherpetic Neuralgia

FDA Approves New Treatment for Diabetic Peripheral Neuropathy, Postherpetic Neuralgia

By

The FDA has approved Lyrica CR, a once-daily treatment for the management of neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia.

Chronic Daily Headache: New Subtype Identified in Case Series

Chronic Daily Headache: New Subtype Identified in Case Series

By

A recently published case series describes a new subtype of chronic daily headache that appears to be associated with elevated cerebrospinal fluid pressure.

Durolane Approved for Treatment of Osteoarthritis Knee Pain

Durolane Approved for Treatment of Osteoarthritis Knee Pain

By

The FDA has approved Durolane for the treatment of pain associated with knee osteoarthritis, which relieved pain and restored function for up to 6 months in patients.

FDA Approves Duzallo, Lesinurad Plus Allopurinol Combo Drug, for Gout

FDA Approves Duzallo, Lesinurad Plus Allopurinol Combo Drug, for Gout

By

The FDA approved Duzallo, a fixed-dose tablet combining lesinurad and allopurinol, for the treatment of uncontrolled gout.

More Articles by Diana Ernst

Sign Up for Free e-Newsletters